跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
李 嘉華
教授
,
醫學檢驗暨生物技術學系
合聘教授
,
醫學生物科技博士學位學程
成員
,
臺北醫學大學癌症轉譯研究中心
https://orcid.org/0000-0002-6015-2239
電子郵件
chlee
tmu.edu
tw
h-index
2162
引文
25
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2026
每年研究成果
概覽
指紋
網路
專案
(20)
研究成果
(55)
資料集
(5)
類似的個人檔案
(6)
指紋
查看啟用 Chia-Hwa Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinic Receptor
92%
Breast Cancer
85%
Malignant Neoplasm
60%
Nicotine
58%
Randomized Controlled Trial
46%
Thyroid Cancer
40%
Carcinogen
36%
Colon Carcinoma
36%
Neoplasm
35%
Liver Cancer
26%
Carcinogenesis
25%
Molecular Target
24%
Imatinib
23%
Histone Deacetylase 1
23%
Nicotine-Derived Nitrosamine Ketone
23%
Polyphenol
23%
Phloretin
23%
Terbinafine
23%
Epidermal Growth Factor Receptor
23%
Anaplastic Thyroid Carcinoma
20%
Histone Deacetylase Inhibitor
19%
Histone
19%
Estrogen
18%
Normal Human
17%
Triple Negative Breast Cancer
17%
Chronic Myeloid Leukemia
16%
Glucose Transporter 2
15%
Biological Marker
15%
Vasculotropin
14%
Caspase 8
14%
Histone Deacetylase 2
14%
Cyclin D1
12%
Protein Tyrosine Kinase Inhibitor
12%
Malus pumila
12%
Panobinostat
12%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanone
12%
Carcinogenicity
11%
Navitoclax
11%
Esophageal Squamous Cell Carcinoma
11%
Paclitaxel
11%
Mitomycin
11%
Lesinurad
11%
Endocrine Ophthalmopathy
11%
Cyclin D3
11%
Hyperuricemia
11%
Nuclear Factor
11%
Epidermal Growth Factor
11%
Anaplastic Carcinoma
11%
Glucose Regulated Protein 94
11%
Epigallocatechin Gallate
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Genomics
40%
Differentially Expressed Gene
34%
Gene Expression
30%
Programmed Cell Death
28%
CRISPR/Cas9
26%
Colon
23%
Nicotinic Acetylcholine Receptor
23%
Carcinogenesis
22%
Targeted Therapy
21%
Promoter Region
18%
Molecular Mechanism
18%
Nicotine
17%
Animal Model
17%
Cell Cycle Arrest
16%
Cell Cycle Checkpoint
16%
Single-Nucleotide Polymorphism
16%
Signal Transduction
16%
Real-Time Polymerase Chain Reaction
15%
Heat Shock Protein
15%
Lentivirus
15%
Phosphotransferase
15%
Kinase
15%
Luciferase
14%
Messenger RNA
13%
Mouse Model
13%
Prognostic Biomarker
13%
Transcription
12%
Overall Survival
12%
RNA Sequencing
11%
Myeloid
11%
down Regulation
11%
Binding Protein
11%
Oncogene
11%
Glucose-Regulated Protein
11%
Hepatitis B Virus
11%
Lysyl Oxidase
11%
G1/S Transition
11%
Quantitative Technique
11%
HMGA2
11%
Membrane Protein
11%
Tumor-Related Gene
11%
Genome Editing
11%
Receptor Upregulation
11%
ABL (Gene)
11%
Doxorubicin
11%
Vascular Endothelial Growth Factor
11%
Platelet Derived Growth Factor Receptor Alpha
11%
CHRNB4
11%
Paxillin
11%
Medicine and Dentistry
Breast Cancer
61%
Nicotinic Receptor
46%
Nicotine
37%
Cancer Cell
36%
Meta-Analysis
34%
Programmed Cell Death
24%
Carcinogenesis
24%
Tocopherol
23%
Epithelial Cell
23%
Invasive Carcinoma
23%
Randomized Controlled Trial
23%
Cancer
15%
Real-Time Polymerase Chain Reaction
15%
Protein Expression
14%
Breast Cancer Cell Line
14%
Metastatic Carcinoma
14%
In Vitro
13%
Prostate Tissue
13%
Breast Tissue
13%
Liver Tissue
13%
Cell Death
13%
Malignant Neoplasm
11%
Thyroid Cancer
11%
down Regulation
11%
Thyroid Gland
11%
Chronic Myelogenous Leukemia
11%
Colon
11%
Circulating Tumor Cell
11%
Breast Carcinogenesis
11%
Deacetylation
11%
Papillary Thyroid Cancer
11%
Leukemia Cell
11%
Receptor Upregulation
11%
Cervical Lymph Node
11%
Epigallocatechin Gallate
11%
Bisphosphonate
11%
Parathyroid
11%
Systematic Review
11%
Lung
11%
Polyphenol
11%
Genetics
11%
Neck Dissection
11%
Tumor Suppressor Protein
11%
Tyrosine-Kinase Inhibitor
11%
Mediator
11%
Histone
11%
Ferroptosis
11%
Wound Closure
11%
Estrogen
11%
Navitoclax
11%
